Trastuzumab (Herceptin) in patients with HER-2-overexpressing metastatic or locally advanced transitional cell carcinoma of the bladder: report on 7 patients

Salzberg, Marc; Borner, Markus; Bauer, Jean-Alexandre; Morant, Rudolf; Rauch, Daniel; Rochlitz, Christoph (2006). Trastuzumab (Herceptin) in patients with HER-2-overexpressing metastatic or locally advanced transitional cell carcinoma of the bladder: report on 7 patients. European journal of cancer, 42(15), pp. 2660-1. Amsterdam: Elsevier 10.1016/j.ejca.2006.06.009

Full text not available from this repository. (Request a copy)

Item Type:	Journal Article (Further Contribution)
Division/Institute:	04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology
UniBE Contributor:	Borner, Markus, Rauch, Daniel
ISSN:	0959-8049
ISBN:	16934972
Publisher:	Elsevier
Language:	English
Submitter:	Factscience Import
Date Deposited:	04 Oct 2013 14:49
Last Modified:	05 Dec 2022 14:15
Publisher DOI:	10.1016/j.ejca.2006.06.009
PubMed ID:	16934972
Web of Science ID:	000241926300042
URI:	https://boris.unibe.ch/id/eprint/20455 (FactScience: 3753)